Skip to main content
×
×
Home

Management of the renal adverse effects of lithium

  • Sumeet Gupta, Mukesh Kripalani, Udayan Khastgir and Joe Reilly
Summary

Lithium is one of the most effective psychotropic drugs we have, but it is underused because of its low therapeutic index, the need for regular blood tests and perceptions about its adverse effects, including renal problems. The last include urinary concentration deficits and diabetes insipidus, chronic kidney disease (including renal failure), nephrotic syndrome, hypercalcaemia, hyperparathyroidism and distal tubular acidosis. This article reviews these adverse effects with special emphasis on their management.

Copyright
Corresponding author
Dr Sumeet Gupta, Consultant Psychiatrist, West Park Hospital, Edward Pease Way, Darlington DL2 2TS, UK. Email: Sumeet.Gupta@nhs.net
Footnotes
Hide All

Declaration of Interest

S.G. has received financial support to attend conferences from AstraZeneca and Lundbeck. M.K. has received financial support to attend a conference from Bristol-Myers Squibb and Reckitts.

Footnotes
References
Hide All
Baldessarini, RJ, Tondo, L, Viguera, AC (1999) Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disorder 1: 1724.
Bassilios, N, Martel, P, Godard, V et al (2008) Monitoring of glomerular filtration rate in lithium-treated outpatients: an ambulatory laboratory database surveillance. Nephrology Dialysis Transplantation 23: 562–5.
Bendz, H, Aurell, M, Balldin, J et al (1994) Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrology Dialysis Transplantation 9: 1250–4.
Bendz, H, Schon, S, Attman, PO et al (2010) Renal failure occurs in chronic lithium treatment but is uncommon. Kidney International 77: 219–24.
Bosquet, S, Descombes, E, Gauthier, T et al (1997) Nephrotic syndrome during lithium therapy. Nephrology Dialysis Transplantation 12: 2728–31.
Boton, R, Gaviria, M, Batlle, DC (1987) Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. American Journal of Kidney Diseases 10: 329–45.
Broome, JT, Solorzano, CC (2011) Lithium use and primary hyperparathyroidism. Endocrine Practice 17 (suppl 1): 31–5.
Decina, P, Pedicelli, C, Diana, G et al (2010) Lithium-induced tardive nephropathy: MRI contribution to the detection of pre-symptomatic renal abnormalities. Journal of Psychopathology 16: 321–5.
DePaulo, JR Jr., Correa, EI, Sapir, DG (1986) Renal function and lithium: a longitudinal study. American Journal of Psychiatry 143: 892–5.
Duflot, JP, Dore, C, Fellion, G et al (1973) Use of lithium carbonate in a psychiatric institution. Annales Medico Psychologiques 2: 311–21.
Farres, MT, Ronco, P, Saadoun, D et al (2003) Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 229: 570–4.
Ferrier, IN, Ferrie, LJ, Macritchie, KA (2006) Old drug, new data: revisiting… lithium therapy. Advances in Psychiatric Treatment 12: 256–64.
Gill, J, Singh, H, Nugent, K (2003) Acute lithium intoxication and neuroleptic malignant syndrome. Pharmacotherapy 23: 811–5.
Gitlin, M (1999) Lithium and the kidney: an updated review. Drug Safety 20: 231–43.
Grandjean, EM, Aubry, JM (2009) Lithium: updated human knowledge using an evidence-based approach. Part III: clinical safety. CNS Drugs 23: 397418.
Gregoor, PS, De Jong, GM (2007) Lithium hypercalcaemia, hyperparathyroidism, and cinacalcet. Kidney International 71: 470.
Grunfeld, JP, Rossier, BC (2009) Lithium nephrotoxicity revisited. Nature Reviews Nephrology 5: 270–6.
Ishani, A, Grandits, GA, Grimm, RH et al (2006) Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate and hematocrit with the 25 year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. Journal of the American Society of Nephrology 17: 1444–52.
Jefferson, JW (2010) A clinician's guide to monitoring kidney function in lithium-treated patients. Journal of Clinical Psychiatry 71: 1153–7.
Kanfer, A, Blondiaux, I (2000) Renal and metabolic complications of lithium. Nephrologie 21: 6570.
Kehoe, RF (1994) A cross-sectional study of glomerular function in 740 unselected lithium patients. Acta Psychiatrica Scandinavica 89: 6871.
Khandwala, HM, van Uum, S (2006) Reversible hypercalcaemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocrine Practice 12: 54–8.
Knebel, RJ, Rosenlicht, N, Collins, L (2010) Lithium carbonate maintenance therapy in a hemodialysis patient with end-stage renal disease. American Journal of Psychiatry 167: 1409–10.
Kripalani, M, Shawcross, J, Reilly, J et al (2009) Lithium and chronic kidney disease. BMJ 339: b2452.
Kusalic, M, Engelsmann, F (1996) Renal reactions to changes of lithium dosage. Neuropsychobiology 34: 113–6.
Lederer, E, Dacso, CC, Tran, MD (2012) Lithium nephropathy. Medscape Reference: Drugs, Diseases & Procedures (http://emedicine.medscape.com/article/242772, accessed 4 July 2012).
Lepkifker, E, Sverdlik, A, Iancu, I et al (2004) Renal insufficiency in long-term lithium treatment. Journal of Clinical Psychiatry 65: 850–6.
Markowitz, GS, Radhakrishnan, J, Kambham, N et al (2000) Lithium nephro toxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology 11: 1439–48.
McKnight, RF, Adida, M, Budge, K et al (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379: 721–8.
Miller, AL, Bowden, CL, Plewes, J (1985) Lithium and impairment of renal concentrating ability. Journal of Affective Disorder 9: 115–9.
National Collaborating Centre for Chronic Conditions (2008a) Chronic Kidney Disease: Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care (NICE Clinical Guideline 73). National Institute for Health and Clinical Excellence.
National Collaborating Centre for Chronic Conditions (2008b) Type 2 Diabetes: The Management of Type 2 Diabetes (NICE Clinical Guideline 66). National Institute for Health and Clinical Excellence.
National Collaborating Centre for Mental Health (2006) Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents in Primary and Secondary Care (NICE Clinical Guideline 38). National Institute for Health and Clinical Excellence.
Presne, C, Fakhouri, F, Noël, LH et al (2003) Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney International 64: 585–92.
Raja, M (2011) Lithium and kidney, 60 years later. Current Drug Safety 6: 291303.
Reilly, JG, Close, H, Main, J et al (2009) Renal outcomes in people with bipolar disorder treated with lithium: a retrospective cohort database study. Pharmacoepidemiology and Drug Safety 18 (suppl 1): S202.
Saunders, BD, Saunders, EF, Gauger, PG (2009) Lithium therapy and hyperparathyroidism: an evidence-based assessment. World Journal of Surgery 33: 2314–23.
Schou, M (2003) Lithium prophylaxis: myths and realities. Focus 1: 53–7.
Stevens, LA, Coresh, J, Greene, T et al (2006) Assessing kidney function: measured and estimated glomerular filtration rate. New England Journal of Medicine 354: 2473–83.
Stevens, LA, Coresh, J, Feldman, HI et al (2007) Evaluation of the modification of diet in renal disease study equation in large diverse population. Journal of the American Society of Nephrology 18: 2749–57.
Stone, KA (1999) Lithium-induced nephrogenic diabetes insipidus. Journal of the American Board of Family Medicine 12: 43–7.
Szalat, A, Mazeh, H, Freund, HR (2009) Lithium-associated hyperparathyroidism: report of four cases and review of the literature. European Journal of Endocrinology 160: 317–23.
Weinstein, JR, Anderson, S (2010) The aging kidney: physiological changes. Advances in Chronic Kidney Disease 17: 302–7.
Werneke, U, Ott, M, Renberg, ES et al (2012) A decision analysis of long-term lithium treatment and the risk of renal failure. Acta Psychiatrica Scandinavica 126: 186–97.
Young, AH, Hammond, JM (2007) Lithium in mood disorders: increasing evidence base, declining use? British Journal of Psychiatry 191: 474–6.
Young, AH (2011) More good news about the magic ion: lithium may prevent dementia. British Journal of Psychiatry 198: 336–7.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Management of the renal adverse effects of lithium

  • Sumeet Gupta, Mukesh Kripalani, Udayan Khastgir and Joe Reilly
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *